Sinco Pharmaceuticals Holdings Limited

Informe acción SEHK:6833

Capitalización de mercado: HK$518.4m

Salud financiera de hoja de balance de Sinco Pharmaceuticals Holdings

Salud financiera controles de criterios 6/6

Sinco Pharmaceuticals Holdings tiene un patrimonio de accionistas total de CN¥628.1M y una deuda total de CN¥241.7M, lo que sitúa su ratio deuda-patrimonio en 38.5%. Sus activos y pasivos totales son CN¥1.9B y CN¥1.3B respectivamente. El BAIT de Sinco Pharmaceuticals Holdings es de CN¥116.5M, por lo que su ratio de cobertura de intereses es de 30.3. Tiene efectivo e inversiones a corto plazo que ascienden a CN¥437.9M.

Información clave

38.5%

Ratio deuda-patrimonio

CN¥241.74m

Deuda

Ratio de cobertura de intereses30.3x
EfectivoCN¥437.92m
PatrimonioCN¥628.05m
Total pasivoCN¥1.26b
Activos totalesCN¥1.89b

Actualizaciones recientes sobre salud financiera

Recent updates

Some Investors May Be Willing To Look Past Sinco Pharmaceuticals Holdings' (HKG:6833) Soft Earnings

Apr 02
Some Investors May Be Willing To Look Past Sinco Pharmaceuticals Holdings' (HKG:6833) Soft Earnings

Sinco Pharmaceuticals Holdings Limited (HKG:6833) Might Not Be As Mispriced As It Looks

Mar 08
Sinco Pharmaceuticals Holdings Limited (HKG:6833) Might Not Be As Mispriced As It Looks

Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

Nov 07
Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

A Look At The Intrinsic Value Of Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Jun 26
A Look At The Intrinsic Value Of Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

May 30
Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

Sinco Pharmaceuticals Holdings (HKG:6833) Has A Pretty Healthy Balance Sheet

Oct 26
Sinco Pharmaceuticals Holdings (HKG:6833) Has A Pretty Healthy Balance Sheet

Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Might Deserve Your Attention Today

Feb 04
Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Might Deserve Your Attention Today

I Ran A Stock Scan For Earnings Growth And Sinco Pharmaceuticals Holdings (HKG:6833) Passed With Ease

Oct 25
I Ran A Stock Scan For Earnings Growth And Sinco Pharmaceuticals Holdings (HKG:6833) Passed With Ease

Little Excitement Around Sinco Pharmaceuticals Holdings Limited's (HKG:6833) Earnings

Jun 10
Little Excitement Around Sinco Pharmaceuticals Holdings Limited's (HKG:6833) Earnings

Sinco Pharmaceuticals Holdings (HKG:6833) Could Easily Take On More Debt

May 24
Sinco Pharmaceuticals Holdings (HKG:6833) Could Easily Take On More Debt

Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Is An Interesting Stock

Apr 20
Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Is An Interesting Stock

We're Not So Sure You Should Rely on Sinco Pharmaceuticals Holdings' (HKG:6833) Statutory Earnings

Feb 16
We're Not So Sure You Should Rely on Sinco Pharmaceuticals Holdings' (HKG:6833) Statutory Earnings

How Much Did Sinco Pharmaceuticals Holdings'(HKG:6833) Shareholders Earn From Share Price Movements Over The Last Three Years?

Jan 11
How Much Did Sinco Pharmaceuticals Holdings'(HKG:6833) Shareholders Earn From Share Price Movements Over The Last Three Years?

Should You Be Excited About Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 51% Return On Equity?

Dec 07
Should You Be Excited About Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 51% Return On Equity?

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (CN¥1.4B) de 6833 superan a sus pasivos a corto plazo (CN¥1.2B).

Pasivo a largo plazo: Los activos a corto plazo de 6833 (CN¥1.4B) superan a sus pasivos a largo plazo (CN¥30.6M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: 6833 tiene más efectivo que su deuda total.

Reducción de la deuda: El ratio deuda-patrimonio de 6833 ha pasado de 638.1% a 38.5% en los últimos 5 años.

Cobertura de la deuda: La deuda de 6833 está bien cubierta por el flujo de caja operativo (146.3%).

Cobertura de intereses: Los pagos de intereses de la deuda de 6833 están bien cubiertos por el BAIT (30.3x cobertura).


Hoja de balance


Descubre empresas con salud financiera

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target